How EU Pharma Reform Changes Could Affect The ATMP ‘Hospital Exemption’

 
• By Ian Schofield

One of the key challenges facing the Hungarian presidency of the Council of the EU in the second half of 2024 will be the proposals for an overhaul of the EU pharmaceutical legislation, which were amended by the European parliament in April. In the latest in a series of articles on progress with the reform, the Pink Sheet examines the issues surrounding the hospital exemption for advanced therapies.

cell culture experiments at cell culture laboratory
Some advanced therapies can be made in EU hospitals under specific circumstances • Source: Shutterstock

More from Europe

More from Geography